Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 11:27 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
View All Commentary (GILD)
Recs
NYCKrebs (94.13) Submitted: 1/09/07 12:52 AM : Start Price: $32.52 GILD Score: 55.76
Tomorrow the JP Morgan Biotech conference will explain the recent purchase that scared the price of this stock down. They diversified their targeted disease base without explination. Tomorrow investors will get there security blanket back and will retun to this company.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK